X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (150511) 150511
Book Review (24768) 24768
Publication (6818) 6818
Newsletter (6100) 6100
Newspaper Article (1831) 1831
Magazine Article (940) 940
Conference Proceeding (508) 508
Book Chapter (488) 488
Dissertation (196) 196
Book / eBook (171) 171
Web Resource (116) 116
Trade Publication Article (112) 112
Reference (108) 108
Government Document (24) 24
Transcript (24) 24
Paper (17) 17
Data Set (10) 10
Journal / eJournal (10) 10
Streaming Video (6) 6
Presentation (3) 3
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (128798) 128798
humans (98797) 98797
male (58943) 58943
animals (51519) 51519
female (48729) 48729
anti-inflammatory agents - therapeutic use (35863) 35863
adult (27982) 27982
anti-inflammatory agents, non-steroidal - therapeutic use (26715) 26715
middle aged (26304) 26304
anti-inflammatory agents - pharmacology (24250) 24250
pharmacology & pharmacy (22519) 22519
rats (21141) 21141
mice (20083) 20083
inflammation (18550) 18550
aged (18341) 18341
anti-inflammatory agents, non-steroidal - pharmacology (17006) 17006
anti-inflammatory agents, non-steroidal - adverse effects (15477) 15477
anti-inflammatory agents - administration & dosage (14803) 14803
treatment outcome (14208) 14208
anti-inflammatory drugs (13513) 13513
abridged index medicus (12337) 12337
anti-inflammatory agents, non-steroidal - administration & dosage (12280) 12280
nonsteroidal anti-inflammatory drugs (12120) 12120
research (9823) 9823
analysis (9608) 9608
adolescent (9603) 9603
dose-response relationship, drug (8871) 8871
chemistry, medicinal (8134) 8134
time factors (8085) 8085
disease models, animal (7700) 7700
nonsteroidal antiinflammatory drugs (7540) 7540
immunology (7485) 7485
risk factors (7452) 7452
care and treatment (7447) 7447
anti-inflammatory agents - adverse effects (7257) 7257
child (7074) 7074
medicine, general & internal (6900) 6900
administration, topical (6637) 6637
drug therapy, combination (6602) 6602
expression (6580) 6580
inflammation - drug therapy (6492) 6492
double-blind method (6316) 6316
biochemistry & molecular biology (6306) 6306
gastroenterology & hepatology (6216) 6216
rats, wistar (5969) 5969
anti-inflammatory (5952) 5952
drug therapy (5952) 5952
rheumatology (5854) 5854
pain (5663) 5663
health aspects (5656) 5656
drugs (5443) 5443
rats, sprague-dawley (5400) 5400
cytokines (5274) 5274
anti-inflammatory agents, non-steroidal - chemistry (5205) 5205
surgery (5173) 5173
cells, cultured (5087) 5087
therapy (5071) 5071
inhibition (5027) 5027
arthritis, rheumatoid - drug therapy (4985) 4985
anti-inflammatory agents - chemistry (4941) 4941
anti-inflammatory agents (4871) 4871
disease (4828) 4828
administration, oral (4759) 4759
aged, 80 and over (4737) 4737
rheumatoid-arthritis (4684) 4684
cells (4677) 4677
plant extracts - pharmacology (4666) 4666
cell line (4594) 4594
oxidative stress (4572) 4572
nf-kappa-b (4545) 4545
aspirin (4521) 4521
double-blind (4481) 4481
activation (4454) 4454
prospective studies (4440) 4440
steroids (4363) 4363
cancer (4343) 4343
arthritis (4340) 4340
in-vitro (4315) 4315
corticosteroids (4265) 4265
medicine & public health (4258) 4258
retrospective studies (4215) 4215
dermatology (4187) 4187
follow-up studies (4009) 4009
apoptosis (4008) 4008
analgesics (3964) 3964
neurosciences (3935) 3935
young adult (3928) 3928
antioxidants (3906) 3906
cell biology (3806) 3806
diagnosis, differential (3761) 3761
immunosuppressive agents - therapeutic use (3728) 3728
child, preschool (3666) 3666
glucocorticoids (3602) 3602
edema - drug therapy (3550) 3550
anti-inflammatory agents, non-steroidal - pharmacokinetics (3529) 3529
nf-kappa b - metabolism (3514) 3514
macrophages (3509) 3509
prevention (3460) 3460
clinical trials as topic (3421) 3421
clinical neurology (3415) 3415
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (154) 154
Online Resources - Online (72) 72
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
UofT at Mississauga - Stacks (5) 5
Sunnybrook Health Sciences Centre - Holland Stacks (3) 3
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Gerstein Science - Periodical Stacks (1) 1
Media Commons - Audio Visual (1) 1
Mt Sinai Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (140971) 140971
German (4047) 4047
French (3612) 3612
Japanese (2425) 2425
Russian (1819) 1819
Spanish (1539) 1539
Italian (1470) 1470
Chinese (1252) 1252
Polish (681) 681
Dutch (319) 319
Danish (283) 283
Portuguese (266) 266
Swedish (206) 206
Romanian (186) 186
Czech (185) 185
Hungarian (185) 185
Korean (185) 185
Norwegian (172) 172
Turkish (112) 112
Croatian (110) 110
Finnish (104) 104
Ukrainian (92) 92
Bulgarian (69) 69
Hebrew (64) 64
Slovak (43) 43
Serbian (36) 36
Lithuanian (25) 25
Arabic (6) 6
Bosnian (5) 5
Afrikaans (4) 4
Greek (4) 4
Icelandic (4) 4
Persian (3) 3
Slovenian (2) 2
Indonesian (1) 1
Latin (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1974, Medicinal chemistry : a series of monographs, ISBN 9780126239010, Volume 13, 2 v.
Book
Anti-inflammatory & anti-allergy agents in medicinal chemistry, ISSN 1871-5230, 2006
Journal
European Journal of Medicinal Chemistry, ISSN 0223-5234, 08/2015, Volume 101, pp. 81 - 95
A series of triazin–3(2 )–one derivatives bearing 1,3,4–oxadiazole were synthesized, characterized and evaluated for anti–inflammatory and analgesic... 
Anti–inflammatory | 1,3,4–oxadiazole | Cyclooxygenase | Analgesic | 1,2,4–triazine | 1,2,4-triazine | Anti-inflammatory | 1,3,4-oxadiazole | 1,2,4etriazine | Antieinflammatory | 1,3,4eoxadiazole | CHEMISTRY, MEDICINAL | DRUG DISCOVERY | DENATURATION | SERUM | MODEL | ARTHRITIS | INHIBITION | PAIN | NSAIDS | ALBUMIN | EXTRACT | Analgesics - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Structure-Activity Relationship | Pain - chemically induced | Formaldehyde | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Dose-Response Relationship, Drug | Analgesics - chemical synthesis | Oxadiazoles - pharmacology | Pain - drug therapy | Behavior, Animal - drug effects | Triazines - chemistry | Molecular Structure | Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis | Oxadiazoles - chemistry | Disease Models, Animal | Stomach Ulcer - chemically induced | Triazines - pharmacology | Stomach Ulcer - drug therapy | Rats | Cyclooxygenase Inhibitors - chemistry | Edema - drug therapy | Molecular Dynamics Simulation | Cyclooxygenase Inhibitors - pharmacology | Animals | Analgesics - chemistry | Triazines - chemical synthesis | Cyclooxygenase 2 - metabolism | Cyclooxygenase Inhibitors - chemical synthesis | Mice | Carrageenan | Cyclooxygenase 1 - metabolism | Edema - chemically induced | Kinetics | Proteins | COX-2 inhibitors | Isoenzymes | Analysis | Denaturation | Chemical properties | Indomethacin | Liability (Law) | Molecular dynamics | Index Medicus
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 7, pp. 1320 - 1329.e3
Background & Aims Infliximab, a tumor necrosis factor antagonist, is effective for treating patients with Crohn’s disease (CD) and ulcerative colitis (UC). We... 
Gastroenterology and Hepatology | Personalized Medicine | Pharmacokinetics | Therapeutic Drug Monitoring | Monoclonal Antibody | DOSE INTENSIFICATION | MAINTENANCE | THERAPY | CROHNS-DISEASE | EFFICACY | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | WITHDRAWAL | Drug Costs | Recurrence | Crohn Disease - economics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Male | Colitis, Ulcerative - immunology | Gastrointestinal Agents - economics | Antibodies, Monoclonal - blood | Drug Dosage Calculations | Anti-Inflammatory Agents - adverse effects | Infliximab | Crohn Disease - diagnosis | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Colitis, Ulcerative - drug therapy | Gastrointestinal Agents - pharmacokinetics | Anti-Inflammatory Agents - economics | Tertiary Care Centers | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Colitis, Ulcerative - blood | Crohn Disease - immunology | Remission Induction | Anti-Inflammatory Agents - blood | Algorithms | Belgium | Colitis, Ulcerative - diagnosis | Antibodies, Monoclonal - administration & dosage | Cost-Benefit Analysis | Crohn Disease - blood | Crohn Disease - drug therapy | Gastrointestinal Agents - adverse effects | Gastrointestinal Agents - blood | Colitis, Ulcerative - economics | Drug Monitoring | Antibodies, Monoclonal - economics | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Continuing medical education | Consulting services | Ulcerative colitis | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 06/2015, Volume 207, pp. 18 - 30
Exosomes are naturally occurring nanosized vesicles that have attracted considerable attention as drug delivery vehicles in the past few years. Exosomes are... 
Oxidative stress | Neuroinflammation | Parkinson's disease | Catalase | Exosomes | Blood–brain barrier | Blood-brain barrier | ALZHEIMERS-DISEASE | REPEATED INJECTIONS | MACROPHAGE DELIVERY | MEDIATED TRANSFER | BLOOD-BRAIN-BARRIER | BIOLOGICAL BARRIERS | CHEMISTRY, MULTIDISCIPLINARY | IN-VITRO | PEGYLATED LIPOSOMES | PHARMACOLOGY & PHARMACY | SUPEROXIDE-DISMUTASE | Antioxidants - chemistry | Antioxidants - metabolism | Oxidopamine | Anti-Inflammatory Agents - metabolism | PC12 Cells | Neuroprotective Agents - metabolism | Drug Carriers | Brain - metabolism | Nanoparticles | Parkinsonian Disorders - metabolism | Parkinsonian Disorders - drug therapy | Antiparkinson Agents - chemistry | Anti-Inflammatory Agents - administration & dosage | Female | Neurons - metabolism | Neuroprotective Agents - administration & dosage | Nanomedicine | Disease Models, Animal | Neuroprotective Agents - chemistry | Mice, Inbred C57BL | Solubility | Rats | Technology, Pharmaceutical - methods | Parkinsonian Disorders - chemically induced | Administration, Intranasal | Chemistry, Pharmaceutical | Brain - drug effects | Catalase - metabolism | Catalase - administration & dosage | Animals | Anti-Inflammatory Agents - chemistry | Antioxidants - administration & dosage | RAW 264.7 Cells | Antiparkinson Agents - administration & dosage | Mice | Kinetics | Oxidative Stress - drug effects | Antiparkinson Agents - metabolism | Catalase - chemistry | Drugs | Drug delivery systems | Proteases | Analysis | Antiparkinsonian agents | Vehicles | Index Medicus
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 02/2016, Volume 109, pp. 99 - 106
A series of substituted 1,5-diarylpyrrole-3-alkoxyethyl ethers were previously synthesized and the potential anti-inflammatory and antinociceptive activities... 
COX-2 inhibitors | Antinociceptive agents | Molecular modelling | Antiproliferative activity | Anti-inflammatory agents | 1,5-diarylpyrrole derivatives | CHEMISTRY, MEDICINAL | INDUCED EXPERIMENTAL OSTEOARTHRITIS | RAT | NITRIC-OXIDE DONORS | CANCER | PAIN | ACCURATE DOCKING | CYCLOOXYGENASE-2 INHIBITORS | DRUGS | FORCE-FIELD | AGENTS | Skin Neoplasms - drug therapy | Antineoplastic Agents - chemical synthesis | Humans | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Antineoplastic Agents - therapeutic use | Cyclooxygenase 2 Inhibitors - chemistry | Analgesics - chemical synthesis | Cyclooxygenase 2 Inhibitors - therapeutic use | Adult | Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis | Pyrroles - therapeutic use | Skin - pathology | Cyclooxygenase 2 Inhibitors - chemical synthesis | Skin Neoplasms - pathology | Analgesics - therapeutic use | Cell Line | Models, Molecular | Rats | Edema - drug therapy | Antineoplastic Agents - chemistry | Animals | Pyrroles - chemical synthesis | Hyperalgesia - drug therapy | Analgesics - chemistry | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Cyclooxygenase 2 - metabolism | Halogenation | Pyrroles - chemistry | Cell Proliferation - drug effects | Skin - drug effects | Carrageenin | Hydrogen | Analysis | Pharmacy | Drugstores | Skin | Fluorides | Skin cancer | Index Medicus
Journal Article
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 01/2016, Volume 108, pp. 301 - 308
Hepatitis C virus (HCV) infection is a main cause of chronic liver disease, leading to liver cirrhosis and hepatocellular carcinoma (HCC). The objective of our... 
Antiviral | Diflunisal | Hepatitis C | Hepatocellular carcinom | Hydrazide–hydrazone | Hydrazideehydrazone | NS5B POLYMERASE | CHEMISTRY, MEDICINAL | DEPENDENT RNA-POLYMERASE | ANTICANCER AGENTS | BIOLOGICAL-ACTIVITIES | REPLICATION | HCV | DERIVATIVES | Hydrazide-hydrazone | Apoptosis - drug effects | Antineoplastic Agents - chemical synthesis | Humans | Structure-Activity Relationship | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Hydrazines - chemistry | Carcinoma, Hepatocellular - drug therapy | Antiviral Agents - chemistry | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacology | Molecular Structure | Tumor Cells, Cultured | Hepacivirus - drug effects | Antiviral Agents - pharmacology | Diflunisal - analogs & derivatives | Hydrazines - pharmacology | Diflunisal - pharmacology | Liver Neoplasms - drug therapy | Hydrazones - chemical synthesis | Antineoplastic Agents - chemistry | Hydrazones - chemistry | Hydrazones - pharmacology | Diflunisal - chemistry | Carcinoma, Hepatocellular - pathology | Antiviral Agents - chemical synthesis | Cell Proliferation - drug effects | Drug Screening Assays, Antitumor | Pharmacy | Liver | Drugstores | Hepatoma | Hepatitis C virus | Health aspects | Liver cirrhosis | Antiviral agents | Microbiology | Cell death | Nonsteroidal anti-inflammatory drugs | Index Medicus
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 12/2013, Volume 70, pp. 846 - 856
A series of new -[(benzo)thiazol-2-yl]-2/3-[3,4-dihydroisoquinolin-2(1 )-yl]ethan/propanamide derivatives was synthesized and characterized by H, C NMR and IR... 
Psychotropic activity | Cytotoxicity | Anti-inflammatory activity | Antimicrobial activity | Thiazole | Tetrahydroisoquinoline | NIH 3T3 Cells | Hypoxia - drug therapy | Antineoplastic Agents - chemical synthesis | Humans | Bacteria - drug effects | Seizures - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Crystallography, X-Ray | Antifungal Agents - chemical synthesis | Antifungal Agents - chemistry | Structure-Activity Relationship | Psychomotor Agitation - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Isoquinolines - chemistry | Benzothiazoles - chemical synthesis | Isoquinolines - pharmacology | Anti-Bacterial Agents - chemistry | Psychotropic Drugs - pharmacology | Antineoplastic Agents - pharmacology | Molecular Structure | Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis | Anesthesia, Inhalation | Antifungal Agents - pharmacology | Fungi - drug effects | Benzothiazoles - pharmacology | Models, Molecular | Edema - drug therapy | Psychotropic Drugs - chemistry | Antineoplastic Agents - chemistry | Chemistry, Physical | Anti-Bacterial Agents - chemical synthesis | Animals | Isoquinolines - chemical synthesis | Benzothiazoles - chemistry | Cell Line, Tumor | Anti-Bacterial Agents - pharmacology | Cell Proliferation - drug effects | Mice | Carrageenan | Edema - chemically induced | Drug Screening Assays, Antitumor | Psychotropic Drugs - chemical synthesis | Index Medicus
Journal Article